Skip to main content
. 2021 Jun 9;13:4597–4604. doi: 10.2147/CMAR.S316470

Figure 1.

Figure 1

Kaplan–Meier estimates of DFS: 81.6% in patients with positive BRCA1/2 mutation versus 86.7% in patients with no mutation, P=0.94.